Senior insider sale
Chief Legal Officer at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$230.8K
3.95K shares
What this filing means
DIFABIO ANDREA plans to sell 3.95K shares of XENON PHARMACEUTICALS INC. valued at approximately $230.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/13/2026ACC: 0001193125-26-106681
Officer· Chief Legal Officer
Since Mar 2026
3.95K
Shares to sell
$230.8K
Approx. market value
3.75K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted share unit award vesting
N/A
3/12/2026
3.75KTotal acquired3.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/12/2026 | Restricted share unit award vesting N/A | 3.75K | — |
| Total | 3.75K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.61K
Market value
$156.7K
3/10/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.34K
Market value
$74.1K
3/13/2026
Total
Units
3.95K
Value
$230.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/10/2026 | 2.61K | $156.7K | — | Completed |
| Planned — Approximate Date | ||||
3/13/2026 | 1.34K | $74.1K | NASDAQ | Planned |
| Total | 3.95K | $230.8K | ||